摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(3,5-dichlorophenyl)succinamic acid | 53219-95-7

中文名称
——
中文别名
——
英文名称
N-(3,5-dichlorophenyl)succinamic acid
英文别名
N-(3,5-Dichlorophenyl)-succinamide;4-(3,5-dichloroanilino)-4-oxobutanoic acid
N-(3,5-dichlorophenyl)succinamic acid化学式
CAS
53219-95-7
化学式
C10H9Cl2NO3
mdl
MFCD00169577
分子量
262.092
InChiKey
AKKPXGYDZXXJLI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    66.4
  • 氢给体数:
    2
  • 氢受体数:
    3

SDS

SDS:f1fc0bec530cc310f6c571773d088bff
查看

反应信息

  • 作为反应物:
    描述:
    二丁基二氯化锡N-(3,5-dichlorophenyl)succinamic acid三乙胺 作用下, 以 甲苯 为溶剂, 生成 di-n-butyltin(IV) 3-[(3',5'-dichlorophenylamido)]propanoate
    参考文献:
    名称:
    3-[(3,5-二氯苯基氨基)]丙酸酯有机锡(IV)的合成,光谱表征,X射线结构和生物学筛选
    摘要:
    六个新的有机锡(IV)配合物与通式为R 3 SNL / R 2 SNL 2,其中R = CH 3(1,4),Ñ -C 4 ħ 9(2,5),C 6 H ^ 5(3)或C合成了8 H 17(6)和L = 3-[(3,5-二氯苯基酰胺基)]丙酸,并通过元素分析,FT-IR,NMR(1 H和13C)光谱研究和质谱。光谱结果表明,配体通过羧酸根基团的氧原子配位。配合物(2)的晶体结构在锡原子周围表现出扭曲的三角-双嘧啶几何形状,而配合物(3)的晶体结构在锡原子周围表现出四面体的几何形状。复合物(1 - 6)筛选了抗真菌和抗细菌的研究,结果表明,三有机锡(IV)配合物具有针对这些微生物比二有机锡(IV)配合物更高的活性。配合物通过Sn(IV)+的静电相互作用与DNA结合 DNA磷酸基团带负电荷的氧的部分,导致变色现象。
    DOI:
    10.1016/j.ica.2013.01.025
  • 作为产物:
    参考文献:
    名称:
    3-[(3,5-二氯苯基氨基)]丙酸酯有机锡(IV)的合成,光谱表征,X射线结构和生物学筛选
    摘要:
    六个新的有机锡(IV)配合物与通式为R 3 SNL / R 2 SNL 2,其中R = CH 3(1,4),Ñ -C 4 ħ 9(2,5),C 6 H ^ 5(3)或C合成了8 H 17(6)和L = 3-[(3,5-二氯苯基酰胺基)]丙酸,并通过元素分析,FT-IR,NMR(1 H和13C)光谱研究和质谱。光谱结果表明,配体通过羧酸根基团的氧原子配位。配合物(2)的晶体结构在锡原子周围表现出扭曲的三角-双嘧啶几何形状,而配合物(3)的晶体结构在锡原子周围表现出四面体的几何形状。复合物(1 - 6)筛选了抗真菌和抗细菌的研究,结果表明,三有机锡(IV)配合物具有针对这些微生物比二有机锡(IV)配合物更高的活性。配合物通过Sn(IV)+的静电相互作用与DNA结合 DNA磷酸基团带负电荷的氧的部分,导致变色现象。
    DOI:
    10.1016/j.ica.2013.01.025
点击查看最新优质反应信息

文献信息

  • Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4)
    作者:Richard Williams、Kari A. Johnson、Patrick R. Gentry、Colleen M. Niswender、Charles D. Weaver、P. Jeffrey Conn、Craig W. Lindsley、Corey R. Hopkins
    DOI:10.1016/j.bmcl.2009.07.072
    日期:2009.9
    This Letter describes the synthesis and SAR of the novel positive allosteric modulator, VU0155041, a compound that has shown in vivo efficacy in rodent models of Parkinson's disease. The synthesis takes advantage of an iterative parallel synthesis approach to rapidly synthesize and evaluate a number of analogs of VU0155041. (C) 2009 Elsevier Ltd. All rights reserved.
  • Design, synthesis, and Gaussia luciferase Assay of triorganotin(IV)-based HCV inhibitors
    作者:Farooq Ali Shah、Kaneez Fatima、Shaista Sabir、Saqib Ali、Andreas Fischer、Mohammad Ishtiaq Qadri
    DOI:10.1007/s00044-014-1242-3
    日期:2015.4
    The discovery and optimization of a novel triorganotin(IV) complexes with anti-HCV properties are presented. Organotin(IV) moiety has the ability to bind phosphate group of RNA backbone. The organotin(IV) moiety is bonded with ligands and groups, which are known for inhibiting HCV enzymes. Triorganotin(IV) complexes were synthesized and evaluated for their potency against HCV by using luciferase assay. Structure-activity relationship studies led to the identification of Tributyltannic[3-(3',4'-dichlorophenylamido)propanoate] (compound 1) as a potent HCV inhibitor, with log IC50 values 0.79 nM in the cell-based assay. Triorganotin(IV) complexes containing chlorine and nitro group display higher potency. Gaussia luciferase Assay shows that among triorganotin(IV) derivatives, butyl substituted triorganotin(IV) complexes are more active than methyl- and phenyl-substituted complexes.HCV infection can lead to hepatocellular carcinoma, and is a major reason for liver transplantation. The worldwide prevalence of chronic HCV infection is estimated to be approaching 270-300 million people, but patients and physicians are still waiting for effective anti-HCV drugs. With this background, organotin(IV) complexes are synthesized and screened against HCV using Gaussia luciferase assay. Organotin(IV) complexes are selected due to their ability to interact with both DNA constituents and enzymes.
  • Synthesis, spectroscopic characterization, X-ray structure and biological screenings of organotin(IV) 3-[(3,5-dichlorophenylamido)]propanoates
    作者:Farooq Ali Shah、Muhammad Sirajuddin、Saqib Ali、Syed Mustansar Abbas、Muhammad Nawaz Tahir、Corrado Rizzoli
    DOI:10.1016/j.ica.2013.01.025
    日期:2013.5
    Six new organotin(IV) complexes with general formula R3SnL/R2SnL2 where R = CH3 (1, 4), n-C4H9 (2, 5), C6H5 (3) or C8H17 (6) and L = 3-[(3,5-dichlorophenylamido)]propanoic acid were synthesized and structurally characterized by elemental analyses, FT-IR, NMR (1H and 13C) spectral studies, and mass spectrometry. Spectroscopic results suggest that the ligand coordinate through oxygen atom of the carboxylate
    六个新的有机锡(IV)配合物与通式为R 3 SNL / R 2 SNL 2,其中R = CH 3(1,4),Ñ -C 4 ħ 9(2,5),C 6 H ^ 5(3)或C合成了8 H 17(6)和L = 3-[(3,5-二氯苯基酰胺基)]丙酸,并通过元素分析,FT-IR,NMR(1 H和13C)光谱研究和质谱。光谱结果表明,配体通过羧酸根基团的氧原子配位。配合物(2)的晶体结构在锡原子周围表现出扭曲的三角-双嘧啶几何形状,而配合物(3)的晶体结构在锡原子周围表现出四面体的几何形状。复合物(1 - 6)筛选了抗真菌和抗细菌的研究,结果表明,三有机锡(IV)配合物具有针对这些微生物比二有机锡(IV)配合物更高的活性。配合物通过Sn(IV)+的静电相互作用与DNA结合 DNA磷酸基团带负电荷的氧的部分,导致变色现象。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐